Neufarn, Germany

Matthias Schneider

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Matthias Schneider: Innovator in Humanized Antibodies

Introduction

Matthias Schneider is a notable inventor based in Neufarn, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of three patents to his name, Schneider's work has the potential to impact cancer treatment and diagnostics.

Latest Patents

Schneider's latest patents include innovative approaches to humanized antibodies against iRHOM2. This invention relates to humanized antibodies or target-binding fragments that retain target binding capacities, specifically binding to human iRhom2. Another significant patent focuses on a protein biomarker and its uses. This invention outlines methods for identifying and treating human subjects with tumors or other diseases by assessing HRG gene expression at a protein level. It also details the administration of anti-HER3 antibodies based on the HRG gene expression levels. Additionally, Schneider's patent includes methods for performing an ELISA, which involves sequential steps of contacting a solid surface with various solutions, each containing specific components necessary for the assay.

Career Highlights

Throughout his career, Matthias Schneider has worked with prominent companies in the biotechnology sector. He has been associated with Daiichi Sankyo Company, Limited and Amgen Inc., where he has contributed to various research and development projects. His expertise in antibody development has positioned him as a valuable asset in the industry.

Collaborations

Schneider has collaborated with notable colleagues, including Sabine Blum and Renee Jeanne Mendell-Harary. These collaborations have further enhanced his research and innovation in the field of biotechnology.

Conclusion

Matthias Schneider's contributions to the development of humanized antibodies and his innovative patents reflect his dedication to advancing medical science. His work has the potential to improve treatment options for patients with tumors and other diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…